These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 955265)

  • 21. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in influenza vaccinces.
    Gregg MB
    J Occup Med; 1974 Oct; 16(10):651-3. PubMed ID: 4616070
    [No Abstract]   [Full Text] [Related]  

  • 23. Influenza and influenza vaccination.
    Goodman RA; Hinman AR; Nolan TF; Brandling-Bennett AD
    Am Fam Physician; 1980 Jan; 21(1):101-5. PubMed ID: 7350730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3 vaccines against influenza--which to choose].
    Holzner A; Stickl H
    Fortschr Med; 1979 Aug; 97(30-31):1305-10. PubMed ID: 468092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiments in the preparation of live influenza B vaccines.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Dev Biol Stand; 1977 Jun 1-3; 39():85-9. PubMed ID: 604138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influenza vaccination in dialysis patients].
    Haldimann B; Descoeudres C
    Schweiz Med Wochenschr; 1978 Jan; 108(2):52-5. PubMed ID: 622534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.
    Douglas RG; Markoff LJ; Murphy BR; Chanock RM; Betts RF; Hayden FG; Levine MM; Van Blerk GA; Sotman SB; Nalin DR
    Infect Immun; 1979 Oct; 26(1):274-9. PubMed ID: 500204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Live influenza vaccines (author's transl)].
    Gerth HJ
    MMW Munch Med Wochenschr; 1977 Jun; 119(24):821-4. PubMed ID: 407467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
    Kobasa D; Takada A; Shinya K; Hatta M; Halfmann P; Theriault S; Suzuki H; Nishimura H; Mitamura K; Sugaya N; Usui T; Murata T; Maeda Y; Watanabe S; Suresh M; Suzuki T; Suzuki Y; Feldmann H; Kawaoka Y
    Nature; 2004 Oct; 431(7009):703-7. PubMed ID: 15470432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
    Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
    Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
    [No Abstract]   [Full Text] [Related]  

  • 38. [Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
    Profeta ML; Ferrante P; Kotseva R
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):410-7. PubMed ID: 597391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The control of influenza.
    Mostow SR
    Am Rev Respir Dis; 1974 Nov; 110(5):542-4. PubMed ID: 4473948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.